These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11131151)

  • 1. Comparison of cytokines and CD80 for enhancement of immunogenicity of cervical cancer cells.
    Kaufmann AM; Gissmann L; Simms P; Schreckenberger C; Qiao L
    Immunobiology; 2000 Nov; 202(4):339-52. PubMed ID: 11131151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro.
    Kaufmann AM; Gissmann L; Street D; Schreckenberger C; Hunter M; Qiao L
    Cell Immunol; 1996 May; 169(2):246-51. PubMed ID: 8620552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT; Grant AJ; Siegel JP
    J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of costimulatory molecules into a human colorectal cancer cell line: requirement of CD54, CD80 and class II MHC expression for enhanced immunogenicity.
    Lindauer M; Rudy W; Gückel B; Doeberitz MV; Meuer SC; Moebius U
    Immunology; 1998 Mar; 93(3):390-7. PubMed ID: 9640250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-1 (CD80)-gene transfer combined with interleukin-12 administration elicits protective and therapeutic immunity against mouse hepatocellular carcinoma.
    Tatsumi T; Takehara T; Kanto T; Kuzushita N; Ito A; Kasahara A; Sasaki Y; Hori M; Hayashi N
    Hepatology; 1999 Aug; 30(2):422-9. PubMed ID: 10421650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of B7.1-transfected human colon cancer cells on the induction of autologous tumour-specific cytotoxic T cells.
    Miyazono Y; Kamogawa Y; Ryo K; Furukawa T; Mitsuhashi M; Yamauchi K; Kameoka T; Hayashi N
    J Gastroenterol Hepatol; 1999 Oct; 14(10):997-1003. PubMed ID: 10530496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential function of CD80- and CD86-transfected human melanoma cells in the presence of IL-12 and IFN-gamma.
    Rudy W; Gückel B; Siebels M; Lindauer M; Meuer SC; Moebius U
    Int Immunol; 1997 Jun; 9(6):853-60. PubMed ID: 9199968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-1(CD80)-transfected human glioma cells and interleukin-12 directly stimulate allogeneic CD8+ T cells.
    Komata T; Tanaka R; Yamamoto K; Oda T; Ono K; Yoshida S; Takahashi M
    J Immunother; 1997 Jul; 20(4):256-64. PubMed ID: 9220315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma.
    Pulaski BA; Clements VK; Pipeling MR; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2000 Apr; 49(1):34-45. PubMed ID: 10782864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
    Ilkovitch D; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of immunogenicity of Jeg3 cells by ectopic expression of HLA-A*0201 and CD80.
    Koc S; Kather A; Markert UR; Dürst M; Schneider A; Kaufmann AM
    Am J Reprod Immunol; 2003 Sep; 50(3):243-53. PubMed ID: 14629030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.
    Takenoyama M; Yoshino I; Eifuku R; So T; Imahayashi S; Sugaya M; Yasuda M; Inoue M; Ichiyoshi Y; Osaki T; Nagashima A; Nomoto K; Yasumoto K
    Jpn J Cancer Res; 2001 Mar; 92(3):309-15. PubMed ID: 11267941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD80-mediated induction of immunostimulation in two ocular melanoma cell lines is augmented by interferon-gamma.
    Mulcahy KA; Alexander S; Platts KE; Wardle C; Sisley K; Rennie IG; Murray AK
    Melanoma Res; 2002 Apr; 12(2):129-38. PubMed ID: 11930109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
    Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
    J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.
    Pettit SJ; Ali S; O'Flaherty E; Griffiths TR; Neal DE; Kirby JA
    Clin Exp Immunol; 1999 Apr; 116(1):48-56. PubMed ID: 10209504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
    Cignetti A; Guarini A; Gillio Tos A; Reato G; Foa R
    Cancer Gene Ther; 2000 Feb; 7(2):167-76. PubMed ID: 10770624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.
    Joki T; Kikuchi T; Akasaki Y; Saitoh S; Abe T; Ohno T
    Int J Cancer; 1999 Aug; 82(5):714-20. PubMed ID: 10417770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.